Documents - Examination of Pharmaceutical Patents from a Public Health Perspective in the Arab Region

General texts on intellectual property rights

IPRs, biodiversity loss, access & benefit sharing, prior informed consent

Intellectual property, trade and competition

Intellectual property and folklore, music and entertainment

Intellectual property and public education

Intellectual property and information and communication technologies

Intellectual property and the protection of biodiversity

Intellectual property and agriculture, food and nutrition

Intellectual property and access to medicines in developing countries

Intellectual property and foreign direct investment

Human rights aspects of intellectual property

Intellectual property and technology transfer: help or hindrance?

Intellectual property and the knowledge, innovations and practices of indigenous peoples and local communities

TRIPS, implementation and Review

ICTSD dialogues on trade, IPRs and sustainable development

Selected new stories published in BRIDGES

Discussion papers and BRIDGES articles on IPRs, trade and sustainable development

Resource Book, Policy Paper, Case Studies and Research Tools

About the UNCTAD-ICTSD project on IPRs

Related UNCTAD and ICTSD activities in this area

Setting an agenda for IP negotiations in the next five years

WIPO: Institutional functioning and relevant developments

WTO Members' Submissions on IPRs

Advancing the reform agenda

Policy Options for Assuring Affordable Access to Essential Medicines

Preserving Public Goods in health, education and learning

Intellectual Property and Free Trade Agreements

Intellectual Property and Geographical Indications

Examination of Pharmaceutical Patents from a Public Health Perspective in the Arab Region

Organized by ICTSD, the United Nations Development Programme (UNDP), and the World Health Organisation (WHO)Cairo, Egypt, 14-15 April 2009

Description | Agenda | Documents

Documents

Meeting Report

Patents in the Context of Public Health: Balance between protection and access to medicines by Germán Velásquez, WHO

Defining Patentability Criteria and Disclosure: TRIPS vs. local flexibilities by Carlos Correa, University of Buenos Aires

TRIPS-Plus health-related provisions under Free Trade Agreements by Mohammed El Said, University of Central Lancashire

Presentations from the region's country patent offices' experiences:

Egypt

Jordan

Morocco

Syria

Tunisia

Copyrights 2021 | iprsonline.org